Insamo

Insamo

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://www.insamo.com

Last Round

Seed

Feb 21, 2024

Total Funding Raised

$12M

Company Overview

Insamo is a biotechnology company that specializes in the discovery of membrane-permeable and orally-available cyclic-peptides with antibody-like binding affinity, utilizing advanced molecular biology and synthetic chemistry to create easily administered oral formulations that improve patient care by replacing traditional biologics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug discovery platformcyclic peptidesmacrocyclic peptidesAI drug discoveryorally available drugsoral peptidesAI biotechundruggable targetscomputational drug discoverypeptide therapeuticsgenerative biologyautomated synthesishigh-throughput screeningHTSmembrane-permeable peptidespreclinical biotechnologydrug discovery as a servicedrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Insamo Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Insamo Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 21, 2024

Key People

Founding team and executive leadership

Timothy Craven

Co-founder And CEO

Founding Team

Insamo Investors

Notable investors and investment history

Insamo Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Insamo Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Insamo's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerkeley, California
Employee Range14
Year Founded2022
Last FundingFeb 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.